Müller glia fused with adult stem cells undergo neural differentiation in human retinal models

dc.contributor.authorBonilla Pons, Sergi Àngel
dc.contributor.authorNakagawa, Shoma
dc.contributor.authorGarreta, Elena
dc.contributor.authorFernández Blanco, Álvaro
dc.contributor.authorPesaresi, Martina
dc.contributor.authorAntin, Justin Christopher d'
dc.contributor.authorSebastian Perez, Ruben
dc.contributor.authorGreco, Daniela
dc.contributor.authorDomínguez Sala, Eduardo
dc.contributor.authorGómez Riera, Raúl
dc.contributor.authorBarraquer Compte, Rafael Igancio
dc.contributor.authorDierssen, Mara
dc.contributor.authorMontserrat Pulido, Núria
dc.contributor.authorCosma, Maria Pia
dc.date.accessioned2022-06-17T10:04:49Z
dc.date.available2022-06-17T10:04:49Z
dc.date.issued2022-03-09
dc.date.updated2022-06-17T09:57:17Z
dc.description.abstractVisual impairments are a critical medical hurdle to be addressed in modern society. Müller glia (MG) have regenerative potential in the retina in lower vertebrates, but not in mammals. However, in mice, in vivo cell fusion between MG and adult stem cells forms hybrids that can partially regenerate ablated neurons.We used organotypic cultures of human retina and preparations of dissociated cells to test the hypothesis that cell fusion between human MG and adult stem cells can induce neuronal regeneration in human systems. Moreover, we established a microinjection system for transplanting human retinal organoids to demonstrate hybrid differentiation.We first found that cell fusion occurs between MG and adult stem cells, in organotypic cultures of human retina as well as in cell cultures. Next, we showed that the resulting hybrids can differentiate and acquire a proto-neural electrophysiology profile when the Wnt/beta-catenin pathway is activated in the adult stem cells prior fusion. Finally, we demonstrated the engraftment and differentiation of these hybrids into human retinal organoids.We show fusion between human MG and adult stem cells, and demonstrate that the resulting hybrid cells can differentiate towards neural fate in human model systems. Our results suggest that cell fusion-mediated therapy is a potential regenerative approach for treating human retinal dystrophies.This work was supported by La Caixa Health (HR17-00231), Velux Stiftung (976a) and the Ministerio de Ciencia e Innovación, (BFU2017-86760-P) (AEI/FEDER, UE), AGAUR (2017 SGR 689, 2017 SGR 926).Published by Elsevier B.V.
dc.format.extent22 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idimarina6545040
dc.identifier.issn2352-3964
dc.identifier.pmid35278743
dc.identifier.urihttps://hdl.handle.net/2445/186734
dc.language.isoeng
dc.publisherElsevier
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.ebiom.2022.103914
dc.relation.ispartofEbiomedicine, 2022, vol. 77
dc.relation.urihttps://doi.org/10.1016/j.ebiom.2022.103914
dc.rightscc by-nc-nd (c) Bonilla Pons, Sergi Àngel et al, 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.sourceArticles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))
dc.subject.classificationTrastorns de la visió
dc.subject.classificationMedicina regenerativa
dc.subject.otherVision disorders
dc.subject.otherRegenerative medicine
dc.titleMüller glia fused with adult stem cells undergo neural differentiation in human retinal models
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
2022_eBioMed_Muller_MontserratN.pdf
Mida:
4.14 MB
Format:
Adobe Portable Document Format